nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—Numbness—Tamoxifen—pancreatic cancer	0.017	0.017	CcSEcCtD
Ceftizoxime—Nephropathy toxic—Gemcitabine—pancreatic cancer	0.0169	0.0169	CcSEcCtD
Ceftizoxime—Sensory loss—Tamoxifen—pancreatic cancer	0.0163	0.0163	CcSEcCtD
Ceftizoxime—Tenderness—Tamoxifen—pancreatic cancer	0.0162	0.0162	CcSEcCtD
Ceftizoxime—Tenderness—Erlotinib—pancreatic cancer	0.016	0.016	CcSEcCtD
Ceftizoxime—Thrombocytosis—Gemcitabine—pancreatic cancer	0.0156	0.0156	CcSEcCtD
Ceftizoxime—Cellulitis—Erlotinib—pancreatic cancer	0.0154	0.0154	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Tamoxifen—pancreatic cancer	0.0141	0.0141	CcSEcCtD
Ceftizoxime—Vaginal infection—Tamoxifen—pancreatic cancer	0.0133	0.0133	CcSEcCtD
Ceftizoxime—Cellulitis—Sunitinib—pancreatic cancer	0.0133	0.0133	CcSEcCtD
Ceftizoxime—Numbness—Fluorouracil—pancreatic cancer	0.0115	0.0115	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Epirubicin—pancreatic cancer	0.0113	0.0113	CcSEcCtD
Ceftizoxime—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.0112	0.0112	CcSEcCtD
Ceftizoxime—Tenderness—Gemcitabine—pancreatic cancer	0.0111	0.0111	CcSEcCtD
Ceftizoxime—Sensory loss—Fluorouracil—pancreatic cancer	0.011	0.011	CcSEcCtD
Ceftizoxime—Tenderness—Fluorouracil—pancreatic cancer	0.0109	0.0109	CcSEcCtD
Ceftizoxime—Cellulitis—Gemcitabine—pancreatic cancer	0.0107	0.0107	CcSEcCtD
Ceftizoxime—Cellulitis—Fluorouracil—pancreatic cancer	0.0105	0.0105	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Doxorubicin—pancreatic cancer	0.0105	0.0105	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.00912	0.00912	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Epirubicin—pancreatic cancer	0.00907	0.00907	CcSEcCtD
Ceftizoxime—Pancytopenia—Tamoxifen—pancreatic cancer	0.00841	0.00841	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Doxorubicin—pancreatic cancer	0.00839	0.00839	CcSEcCtD
Ceftizoxime—Neutropenia—Tamoxifen—pancreatic cancer	0.00828	0.00828	CcSEcCtD
Ceftizoxime—Neutropenia—Erlotinib—pancreatic cancer	0.00819	0.00819	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Epirubicin—pancreatic cancer	0.00799	0.00799	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.0079	0.0079	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00782	0.00782	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00774	0.00774	CcSEcCtD
Ceftizoxime—Thrombocytosis—Epirubicin—pancreatic cancer	0.00746	0.00746	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Doxorubicin—pancreatic cancer	0.00739	0.00739	CcSEcCtD
Ceftizoxime—Pancytopenia—Sunitinib—pancreatic cancer	0.0072	0.0072	CcSEcCtD
Ceftizoxime—Haemoglobin—Tamoxifen—pancreatic cancer	0.00712	0.00712	CcSEcCtD
Ceftizoxime—Neutropenia—Sunitinib—pancreatic cancer	0.00709	0.00709	CcSEcCtD
Ceftizoxime—Haemorrhage—Tamoxifen—pancreatic cancer	0.00709	0.00709	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Tamoxifen—pancreatic cancer	0.00705	0.00705	CcSEcCtD
Ceftizoxime—Haemoglobin—Erlotinib—pancreatic cancer	0.00705	0.00705	CcSEcCtD
Ceftizoxime—Haemorrhage—Erlotinib—pancreatic cancer	0.00701	0.00701	CcSEcCtD
Ceftizoxime—Thrombocytosis—Doxorubicin—pancreatic cancer	0.00691	0.00691	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.0067	0.0067	CcSEcCtD
Ceftizoxime—Erythema multiforme—Tamoxifen—pancreatic cancer	0.0067	0.0067	CcSEcCtD
Ceftizoxime—Erythema multiforme—Erlotinib—pancreatic cancer	0.00663	0.00663	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00634	0.00634	CcSEcCtD
Ceftizoxime—Haemoglobin—Sunitinib—pancreatic cancer	0.0061	0.0061	CcSEcCtD
Ceftizoxime—Haemorrhage—Sunitinib—pancreatic cancer	0.00607	0.00607	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Sunitinib—pancreatic cancer	0.00604	0.00604	CcSEcCtD
Ceftizoxime—Eosinophilia—Fluorouracil—pancreatic cancer	0.00592	0.00592	CcSEcCtD
Ceftizoxime—Neutropenia—Irinotecan—pancreatic cancer	0.00584	0.00584	CcSEcCtD
Ceftizoxime—Phlebitis—Docetaxel—pancreatic cancer	0.0058	0.0058	CcSEcCtD
Ceftizoxime—Pancytopenia—Gemcitabine—pancreatic cancer	0.00578	0.00578	CcSEcCtD
Ceftizoxime—Erythema multiforme—Sunitinib—pancreatic cancer	0.00574	0.00574	CcSEcCtD
Ceftizoxime—Anaemia—Tamoxifen—pancreatic cancer	0.0057	0.0057	CcSEcCtD
Ceftizoxime—Neutropenia—Gemcitabine—pancreatic cancer	0.00569	0.00569	CcSEcCtD
Ceftizoxime—Injection site pain—Epirubicin—pancreatic cancer	0.00568	0.00568	CcSEcCtD
Ceftizoxime—Pancytopenia—Fluorouracil—pancreatic cancer	0.00568	0.00568	CcSEcCtD
Ceftizoxime—Leukopenia—Tamoxifen—pancreatic cancer	0.00552	0.00552	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00538	0.00538	CcSEcCtD
Ceftizoxime—Injection site pain—Doxorubicin—pancreatic cancer	0.00526	0.00526	CcSEcCtD
Ceftizoxime—Cellulitis—Epirubicin—pancreatic cancer	0.0051	0.0051	CcSEcCtD
Ceftizoxime—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00506	0.00506	CcSEcCtD
Ceftizoxime—Haemoglobin—Irinotecan—pancreatic cancer	0.00502	0.00502	CcSEcCtD
Ceftizoxime—Haemorrhage—Irinotecan—pancreatic cancer	0.005	0.005	CcSEcCtD
Ceftizoxime—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00498	0.00498	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00493	0.00493	CcSEcCtD
Ceftizoxime—Haemoglobin—Gemcitabine—pancreatic cancer	0.00489	0.00489	CcSEcCtD
Ceftizoxime—Anaemia—Sunitinib—pancreatic cancer	0.00488	0.00488	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00488	0.00488	CcSEcCtD
Ceftizoxime—Haemorrhage—Gemcitabine—pancreatic cancer	0.00487	0.00487	CcSEcCtD
Ceftizoxime—Haemoglobin—Fluorouracil—pancreatic cancer	0.00481	0.00481	CcSEcCtD
Ceftizoxime—Haemorrhage—Fluorouracil—pancreatic cancer	0.00479	0.00479	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.00476	0.00476	CcSEcCtD
Ceftizoxime—Leukopenia—Sunitinib—pancreatic cancer	0.00473	0.00473	CcSEcCtD
Ceftizoxime—Cellulitis—Doxorubicin—pancreatic cancer	0.00472	0.00472	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Epirubicin—pancreatic cancer	0.00464	0.00464	CcSEcCtD
Ceftizoxime—Erythema multiforme—Gemcitabine—pancreatic cancer	0.0046	0.0046	CcSEcCtD
Ceftizoxime—Convulsion—Sunitinib—pancreatic cancer	0.00458	0.00458	CcSEcCtD
Ceftizoxime—Paraesthesia—Tamoxifen—pancreatic cancer	0.00452	0.00452	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.0045	0.0045	CcSEcCtD
Ceftizoxime—Vaginal infection—Epirubicin—pancreatic cancer	0.00438	0.00438	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00436	0.00436	CcSEcCtD
Ceftizoxime—Pain—Tamoxifen—pancreatic cancer	0.0043	0.0043	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.00429	0.00429	CcSEcCtD
Ceftizoxime—Pain—Erlotinib—pancreatic cancer	0.00426	0.00426	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00422	0.00422	CcSEcCtD
Ceftizoxime—Pancytopenia—Docetaxel—pancreatic cancer	0.0041	0.0041	CcSEcCtD
Ceftizoxime—Vaginal infection—Doxorubicin—pancreatic cancer	0.00405	0.00405	CcSEcCtD
Ceftizoxime—Neutropenia—Docetaxel—pancreatic cancer	0.00404	0.00404	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00403	0.00403	CcSEcCtD
Ceftizoxime—Anaemia—Irinotecan—pancreatic cancer	0.00402	0.00402	CcSEcCtD
Ceftizoxime—Body temperature increased—Erlotinib—pancreatic cancer	0.00394	0.00394	CcSEcCtD
Ceftizoxime—Anaemia—Gemcitabine—pancreatic cancer	0.00392	0.00392	CcSEcCtD
Ceftizoxime—Phlebitis—Epirubicin—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Ceftizoxime—Leukopenia—Irinotecan—pancreatic cancer	0.00389	0.00389	CcSEcCtD
Ceftizoxime—Paraesthesia—Sunitinib—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Ceftizoxime—Anaemia—Fluorouracil—pancreatic cancer	0.00385	0.00385	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Ceftizoxime—Leukopenia—Gemcitabine—pancreatic cancer	0.00379	0.00379	CcSEcCtD
Ceftizoxime—Leukopenia—Fluorouracil—pancreatic cancer	0.00373	0.00373	CcSEcCtD
Ceftizoxime—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00371	0.00371	CcSEcCtD
Ceftizoxime—Pain—Sunitinib—pancreatic cancer	0.00369	0.00369	CcSEcCtD
Ceftizoxime—Phlebitis—Doxorubicin—pancreatic cancer	0.00362	0.00362	CcSEcCtD
Ceftizoxime—Convulsion—Fluorouracil—pancreatic cancer	0.00361	0.00361	CcSEcCtD
Ceftizoxime—Agranulocytosis—Docetaxel—pancreatic cancer	0.00359	0.00359	CcSEcCtD
Ceftizoxime—Pruritus—Tamoxifen—pancreatic cancer	0.00356	0.00356	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00355	0.00355	CcSEcCtD
Ceftizoxime—Pruritus—Erlotinib—pancreatic cancer	0.00352	0.00352	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00348	0.00348	CcSEcCtD
Ceftizoxime—Haemoglobin—Docetaxel—pancreatic cancer	0.00347	0.00347	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00346	0.00346	CcSEcCtD
Ceftizoxime—Haemorrhage—Docetaxel—pancreatic cancer	0.00346	0.00346	CcSEcCtD
Ceftizoxime—Diarrhoea—Tamoxifen—pancreatic cancer	0.00344	0.00344	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00344	0.00344	CcSEcCtD
Ceftizoxime—Body temperature increased—Sunitinib—pancreatic cancer	0.00341	0.00341	CcSEcCtD
Ceftizoxime—Diarrhoea—Erlotinib—pancreatic cancer	0.00341	0.00341	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.0034	0.0034	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00339	0.00339	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00333	0.00333	CcSEcCtD
Ceftizoxime—Erythema multiforme—Docetaxel—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Ceftizoxime—Vomiting—Tamoxifen—pancreatic cancer	0.0032	0.0032	CcSEcCtD
Ceftizoxime—Paraesthesia—Irinotecan—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Ceftizoxime—Hypersensitivity—Sunitinib—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Ceftizoxime—Rash—Tamoxifen—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Ceftizoxime—Dermatitis—Tamoxifen—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Ceftizoxime—Vomiting—Erlotinib—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Ceftizoxime—Rash—Erlotinib—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Ceftizoxime—Dermatitis—Erlotinib—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Ceftizoxime—Paraesthesia—Gemcitabine—pancreatic cancer	0.00311	0.00311	CcSEcCtD
Ceftizoxime—Paraesthesia—Fluorouracil—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Ceftizoxime—Pruritus—Sunitinib—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Ceftizoxime—Pain—Irinotecan—pancreatic cancer	0.00304	0.00304	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Ceftizoxime—Nausea—Tamoxifen—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Ceftizoxime—Pain—Gemcitabine—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Ceftizoxime—Nausea—Erlotinib—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Ceftizoxime—Diarrhoea—Sunitinib—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Ceftizoxime—Pain—Fluorouracil—pancreatic cancer	0.00291	0.00291	CcSEcCtD
Ceftizoxime—Eosinophilia—Epirubicin—pancreatic cancer	0.00288	0.00288	CcSEcCtD
Ceftizoxime—Body temperature increased—Irinotecan—pancreatic cancer	0.00281	0.00281	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00281	0.00281	CcSEcCtD
Ceftizoxime—Anaemia—Docetaxel—pancreatic cancer	0.00278	0.00278	CcSEcCtD
Ceftizoxime—Pancytopenia—Epirubicin—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Ceftizoxime—Vomiting—Sunitinib—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Ceftizoxime—Body temperature increased—Gemcitabine—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Ceftizoxime—Neutropenia—Epirubicin—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Ceftizoxime—Rash—Sunitinib—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Ceftizoxime—Dermatitis—Sunitinib—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Ceftizoxime—Leukopenia—Docetaxel—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Ceftizoxime—Body temperature increased—Fluorouracil—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Ceftizoxime—Eosinophilia—Doxorubicin—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Ceftizoxime—Hypersensitivity—Irinotecan—pancreatic cancer	0.00262	0.00262	CcSEcCtD
Ceftizoxime—Convulsion—Docetaxel—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Ceftizoxime—Nausea—Sunitinib—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Ceftizoxime—Pancytopenia—Doxorubicin—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Ceftizoxime—Neutropenia—Doxorubicin—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Ceftizoxime—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00251	0.00251	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Ceftizoxime—Pruritus—Gemcitabine—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Ceftizoxime—Diarrhoea—Irinotecan—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Ceftizoxime—Agranulocytosis—Epirubicin—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Ceftizoxime—Pruritus—Fluorouracil—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Docetaxel—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Ceftizoxime—Diarrhoea—Gemcitabine—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Ceftizoxime—Haemoglobin—Epirubicin—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Ceftizoxime—Haemorrhage—Epirubicin—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Ceftizoxime—Diarrhoea—Fluorouracil—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Ceftizoxime—Vomiting—Irinotecan—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Ceftizoxime—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Ceftizoxime—Rash—Irinotecan—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Ceftizoxime—Dermatitis—Irinotecan—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Ceftizoxime—Paraesthesia—Docetaxel—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Ceftizoxime—Erythema multiforme—Epirubicin—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Ceftizoxime—Vomiting—Gemcitabine—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Ceftizoxime—Rash—Gemcitabine—pancreatic cancer	0.00218	0.00218	CcSEcCtD
Ceftizoxime—Dermatitis—Gemcitabine—pancreatic cancer	0.00218	0.00218	CcSEcCtD
Ceftizoxime—Haemoglobin—Doxorubicin—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Ceftizoxime—Vomiting—Fluorouracil—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Ceftizoxime—Haemorrhage—Doxorubicin—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Ceftizoxime—Rash—Fluorouracil—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Ceftizoxime—Dermatitis—Fluorouracil—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Ceftizoxime—Nausea—Irinotecan—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Ceftizoxime—Pain—Docetaxel—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Ceftizoxime—Nausea—Gemcitabine—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Ceftizoxime—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Ceftizoxime—Nausea—Fluorouracil—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Ceftizoxime—Body temperature increased—Docetaxel—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Ceftizoxime—Anaemia—Epirubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Ceftizoxime—Leukopenia—Epirubicin—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Ceftizoxime—Hypersensitivity—Docetaxel—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Ceftizoxime—Convulsion—Epirubicin—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Ceftizoxime—Pruritus—Docetaxel—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Ceftizoxime—Anaemia—Doxorubicin—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Ceftizoxime—Leukopenia—Doxorubicin—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Ceftizoxime—Diarrhoea—Docetaxel—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Ceftizoxime—Convulsion—Doxorubicin—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Ceftizoxime—Vomiting—Docetaxel—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Ceftizoxime—Rash—Docetaxel—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Ceftizoxime—Dermatitis—Docetaxel—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Ceftizoxime—Paraesthesia—Epirubicin—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Ceftizoxime—Nausea—Docetaxel—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Ceftizoxime—Pain—Epirubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Ceftizoxime—Paraesthesia—Doxorubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Ceftizoxime—Pain—Doxorubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Ceftizoxime—Body temperature increased—Epirubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Ceftizoxime—Hypersensitivity—Epirubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Ceftizoxime—Body temperature increased—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Ceftizoxime—Pruritus—Epirubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Ceftizoxime—Diarrhoea—Epirubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Ceftizoxime—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Ceftizoxime—Pruritus—Doxorubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Ceftizoxime—Vomiting—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Ceftizoxime—Diarrhoea—Doxorubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Ceftizoxime—Rash—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Ceftizoxime—Dermatitis—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Ceftizoxime—Nausea—Epirubicin—pancreatic cancer	0.000984	0.000984	CcSEcCtD
Ceftizoxime—Vomiting—Doxorubicin—pancreatic cancer	0.000974	0.000974	CcSEcCtD
Ceftizoxime—Rash—Doxorubicin—pancreatic cancer	0.000966	0.000966	CcSEcCtD
Ceftizoxime—Dermatitis—Doxorubicin—pancreatic cancer	0.000965	0.000965	CcSEcCtD
Ceftizoxime—Nausea—Doxorubicin—pancreatic cancer	0.00091	0.00091	CcSEcCtD
